HR Execs on the Move

Sroufe Healthcare Products

www.sroufe.com

 
Sroufe Healthcare Products is a Ligonier, IN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.sroufe.com
  • 601 Sroufe St
    Ligonier, IN USA 46767
  • Phone: 260.894.4171

Executives

Name Title Contact Details

Similar Companies

Walters Healthcare Resources

Walters Healthcare Resources is a Palmer, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Beekley

Founded in 1934, Beekley Corporation has evolved into the world leading supplier of simple innovative medical products that help imaging, surgical, and radiation therapy professionals save time, improve accuracy, enhance communication and provide a better patient experience.   Beekley introduced the X-SPOT, the first ever professional skin marker for diagnostic imaging in 1984. The X-SPOT® replaced a variety of makeshift methods used at the time for communicating an area of concern on film. It quickly became a staple in radiology departments across the country and its quick adaptation in all radiology modalities led Beekley to devote itself to the research and development of simple, low cost, disposable products that would help imaging professionals improve communication, productivity, and patient care.   Today, Beekley`s product line has grown to include a broad range of radiologic skin markers, biopsy and patient care devices for Mammography; Breast Biopsy; Radiation Therapy; MRI; CT-Scan and General Radiology.

Medlink Imaging

Medlink Imaging is a Teterboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

STAAR Surgical Company

STAAR Surgical Company is a Monrovia, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Cytori

Cytori Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. We are a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery and other serious, chronic, and life threatening conditions.